Appointment of Chief Financial Officer
ABBOTINDIA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Abbott India's Board of Directors has approved the appointment of Ms. Maithilee Mistry as the new Chief Financial Officer and Key Managerial Personnel of the company, effective May 6, 2025. The appointment was recommended by the Nomination and Remuneration Committee and the Audit Committee. Ms. Mistry brings over 25 years of finance leadership experience across multinational companies, including her most recent role as CFO of Sanofi Consumer Healthcare India Limited and prior leadership positions at Dow Chemical (in both India and the USA), Omya, and Cognis. She is a qualified Chartered Accountant who began her career with Deloitte India. She is not related to any existing Directors or KMPs and holds 54 shares in the company along with a relative.
This is a routine senior leadership appointment. The incoming CFO has strong multinational finance credentials, which is positive for governance and financial oversight, though no immediate material impact on operations or stock price is expected.